Objective Capital @ObjectiveCap

Thanks @GBReports for giving our Managing Director the opportunity to highlight the work we are accomplishing in the Healthcare and Life Sciences sector as we move into the challenges and opportunities of 2019. #LifeSciences #healthcare #biotech hubs.ly/H0gp31F0

Join @BDPharmaExec, who is moderating a fireside chat breakfast meeting from 7-9AM on January 15 at the Lomas Santa Fe Country Club in Solana Beach on the topic of "Selling a Family Owned Business - Getting Your Thoroughbred to the Finish Line." hubs.ly/H0g6gNv0

1 month ago, @MabVaxThera retained @ObjectiveCap as financial advisors to assist in pursuing strategic alternatives including company acquisition and exploring the sale of certain assets. MabVax and Oncotelic now enter into Reverse Merger Discussions. hubs.ly/H0g3w6K0

10 Articles from Our Contributors You Should Read from #2018: Life Sciences thought-leaders share their insider knowledge. pharmaboardroom.com/articles/10-ar… @rjsaynor @10habits @ObjectiveCap @BDPharmaExec @ThomasCueni @JanssenAP @methylogix @drmarkaware @chesterdavisjr @CarlaMSmith

Our team volunteered at @RealityChangers to help judge the student Speech Tournaments. We're humbled by the drive and tenacity that the students in the Reality Changers program demonstrate, and we look forward to spending time with the organization again.

We're honored that @MaxVabThera has chosen us to advise them on the strategy and sale of their clinical and pre-clinical assets. Interest inquiries should be directed to our managing directors at 858-663-8662. hubs.ly/H0fW5lD0

"In order to have a successful life sciences R&D program, biotech and pharma companies must develop game-changing therapeutics, companion diagnostics and personalized medicines." David Crean (@BDPharmaExec) MD @ObjectiveCap pharmaboardroom.com/article/2018-v… …

David Crean (@BDPharmaExec) Managing Director for @ObjectiveCap examines the venture investment activity in life sciences for 2018. pharmaboardroom.com/article/2018-v… #VentureCapital #lifesciences #biotech #biopharma

Our extensive Life Sciences experience plus our valuations history is what truly separates OCP from other firms offering valuations in this sector. Request a consultation today. #LifeSciences #consultation #experience #strategicpartnership hubs.ly/H0fth_N0

With over 60 years experience and 500 real-world advisory transactions, OCP's team will help you capitalize on your opportunities. Request a consultation today. #LifeSciences #consultation #experience #opportunities #business #strategicpartnership hubs.ly/H0ftkfK0

At OCP we immerse ourselves completely into each client's unique story and business niche to help achieve maximum value and outcomes. Request a consultation today. #LifeSciences #consultation #business #strategicpartnership hubs.ly/H0fthwb0

Elevated Valuations Across the Board for #lifesciences in 2018 David H Crean (@BDPharmaExec), Managing Director for @ObjectiveCap, a leading investment banking advisory firm examines the #healthcare market for 2018. pharmaboardroom.com/article/elevat… …

At OCP we've skillfully taken our clients from inception through IPO with an evaluation process that provides you with 5 key bullet points to create success. Request a consultation today. #IPO #SuccessFactors #consultation #strategicpartnership hubs.ly/H0fthYK0

Thanks to the great coaches! Moderator: Pamela Reeve Judges: Lesley Solomon @DanaFarber David H. Crean, @ObjectiveCap and Sarah MacDonald @LS_Cares

Elevated Valuations Across the Board for #lifesciences in 2018 David H Crean (@BDPharmaExec), Managing Director for @ObjectiveCap, a leading investment banking advisory firm examines the #healthcare market for 2018. pharmaboardroom.com/article/elevat…

OCP's David H. Crean Ph.D. has been selected to sit on the expert judges panel in the @MassBio Petri Dish Nonprofit Pitch challenge to help grow awareness of the #nonprofit community within the life sciences and healthcare ecosystem in Boston, MA. hubs.ly/H0fnClG0

We are pleased to announce that we were the exclusive advisor to @EveryoneCounts on its sale to Votem. Together they will be able to grow their business exponentially. #voting #acquisition #mergers #blockchaintechnology hubs.ly/H0fl-tq0

We're honored that Trever F. Acers, Managing Director of OCP, has been named in The San Diego 500, the book of Influential Business Leaders, 2018 Trever currently leads all aspects of OCP's investment banking services. #InvestmentBanking #SDBusiness hubs.ly/H0dZ0nC0

We're extremely honored to be named as a finalist for the Valuation Firm of the Year in the 17th Annual M&A Advisor Awards. Thank you for acknowledging the work that we do. #healthcare #Biotechnology #lifescience #businessvaluation hubs.ly/H0dQ_lH0

Register now for the July 12 event in La Jolla to learn about the application of Artificial Intelligence and its intersection with Life Science and Healthcare space from keynote speaker and OCP Managing Director, @BDPharmaExec hubs.ly/H0cWBz00